Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinoma

International Journal of Urology

Volumn 13, Issue 7, 2006, Pages 1035-1036

  Lehmann, Jan ^a   Retz, Margitta ^a   Siemer, Stefan ^a   Schreier, Ulrich ^a   Zwergel, Ulrike ^a   Stöckle, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Gemcitabine; Maintenance chemotherapy; Metastatic transitional cell carcinoma

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; GEMCITABINE; METHOTREXATE;

ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; FATIGUE; FEMALE; HUMAN; KIDNEY PELVIS CANCER; LEUKOPENIA; LUNG METASTASIS; MAINTENANCE THERAPY; NAUSEA; NEPHROURETERECTOMY; PRIORITY JOURNAL; RETROPERITONEAL CANCER; SURVIVAL TIME; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA; TREATMENT DURATION; UROGENITAL TRACT TUMOR;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; DEOXYCYTIDINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; RETROPERITONEAL NEOPLASMS; RIBONUCLEOTIDE REDUCTASES; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 33745921206     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01471.x     Document Type: Article

References (6)

1. Albers P, Siener R, Hartlein M et al. Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life. Onkologie 2002; 25: 47-52.
2. Gebbia V, Testa A, Borsellino N et al. Single agent 2′,2′- difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study. Clin. Ter. 1999; 150: 11-15.
3. Lorusso V, Pollera CF, Antimi M et al. A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer. Eur. J. Cancer 1998; 34: 1208-12.
4. Pollera CF, Ceribelli A, Crecco M, Calabresi F. Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study. Ann. Oncol. 1994; 5: 182-4.
5. Zai S, Castagneto B, Marenco D, Botta M. Gemcitabine monochemotherapy in elderly patients with advanced bladder carcinoma: response to treatment and its correlation with the comprehensive geriatric assessment. Proc. Am. Soc. Clin. Oncol. 2003; 22: 425.
6. Sternberg CN, Yagoda A, Scher HI et al. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J. Urol. 1985; 133: 403-7.